公司基本信息 - 公司于2025年5月23日举行年度股东大会，所有提案按2025年5月2日通知中提出的内容得到解决 [1] - 公司是挪威的消费者和宠物健康公司，核心价值观为可持续性、自然资源的优化利用和全程可追溯性，将三文鱼产业的副产品转化为改善人类和宠物健康的成分 [1] - 公司总部位于挪威奥勒松，在奥斯陆、伦敦、苏黎世和帕洛阿尔托设有分支机构 [4] - 公司在奥斯陆证券交易所上市，股票代码为“HBC” [4] 公司产品 - 公司产品包括ProGo®（生物活性肽和胶原蛋白混合物）、OmeGo®（全三文鱼油）和CalGo® / NT-II®三文鱼骨粉（含羟基磷灰石和未变性胶原蛋白） [2] 产品健康益处及成果 - ProGo®可改善铁代谢，提高身体吸收和利用铁的能力，增加能量和活力，还能激活GLP - 1受体，帮助超重成年人减少脂肪 [3] - OmeGo®对免疫健康有益，包括帮助从病毒感染中恢复，改善受颗粒物污染困扰的成年人的呼吸健康和睡眠 [3] - CalGo®对骨骼和关节健康有益，支持健康老龄化和积极的生活方式 [3] - 相关研究成果获得多项专利，发现潜在疗法，还分拆出专注生物技术的公司HBC Immunology（HBCI），该公司已获得外部融资，主要项目针对前列腺癌，其次是卵巢癌，另有一个分子被开发为治疗哮喘的口服、节省类固醇的疗法 [3] 联系方式 - 如需进一步信息，可联系公司首席执行官Jon Olav Ødegård，电话+47 936 32 966，邮箱joo@hofsethbiocare.no [1] 附件 - 附件为2025年年度股东大会会议记录 [4]

HBC recorded total operating revenues of NOK 60.9 million in the first quarter of 2025, compared to NOK 52.4 million in the same period last year. Net operating revenues were NOK 60.7 million, reflecting a 15% increase from Q1 2024 (NOK 52.1 million), driven by continued growth in higher-margin human and pet health segments, despite early-quarter production constraints and ongoing pressure in the commodity oil market. Cost of goods sold (CoGS) amounted to NOK 37.5 million, up from NOK 27.3 million in Q1 202 ...

Nestlé-owned Garden of Life has launched OmeGo® Full Spectrum Omegas on Amazon in the US. Branded as “Norwegian Salmon Oil”, it retains the complete balance and nutritional profile of fresh Atlantic salmon in a softgel format. Joining Garden of Life’s portfolio of health supplements available online, Norwegian Salmon Oil containing OmeGo® is gently liberated from fresh, sashimi-grade salmon and provides whole-fish health benefits from its full spectrum of omegas. It differentiates from a competitive Omega-3 ...

Reference is made to the stock exchange notice published by Hofseth BioCare ASA (the "Company") on 10 March 2025 regarding a contemplated bond issuance. The Company is pleased to announce that it has now successfully placed CHF-denominated unsecured bonds for a total amount of approximately CHF 3.5 million (the "Bonds"). The Bonds were subscribed for by investors in Switzerland and Liechtenstein. Settlement of the Bonds issue is expected to occur simultaneously as the issue date, which is expected to be on ...

The Annual General Meeting of Hofseth BioCare ASA for 2025 will be held at the company's premises at Keiser Wilhelms gate 24, 6003 Ålesund, on 23 May 2025 at 13:00 CET. The notice of the Annual General Meeting is attached. For further information, please contact: Jon Olav Ødegård, CEO of Hofseth BioCare ASA Phone: +47 93632966 E-mail: investor@hofsethbiocare.no About Hofseth BioCare ASA: Hofseth BioCare is a Norwegian consumer and pet health company founded on the core values of sustainability, optimal ut ...